Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate.
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Though some evidence suggests that bisphosphonates (BPs) act directly on osteoclasts to inhibit bone resorption, other evidence suggests that they inhibit the development of the osteoclast. We found an increase in osteoclast recruitment in 2-day-old mice given (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). A threefold increase in 5-bromo-2'-deoxyuridine (BrdU)-labeled osteoclast nuclei was observed on mouse parietal bones 3 days after APD injection. This suggests that inhibition of osteoclast development is not an action of APD in mice of this age. The mechanism of the increased recruitment was investigated. As osteoclast progenitors were not detected on parietal bones in vitro, we looked for an increase in circulating monocytes to account for the recruitment. No such increase was found, but when 51Cr-labeled bone marrow was injected intraperitoneally into mice given APD there was an increase in accumulation of 51Cr in calvaria and in femur and tibia over controls. This increase did not occur when 51Cr-labeled erythrocytes or free 51Cr was injected. We conclude that APD causes increased recruitment of osteoclast precursors by increasing the avidity of bone for hematopoietically derived cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, bisphosphonates have a different mechanism of action that can be associated with normal or even increased osteoclast numbers despite clear antiresorptive effects (129 -138).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [133]
In the citing paper
“and in some cases can paradoxically stimulate the formation of osteoclasts (133).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [133]
Citations
Cites
The acute-phase response after bisphosphonate administration
Adami, S., Bhalla, A. K., Dorizzi, R., Montesanti, F., Rosini, S., Salvagno, G., & Lo Cascio, V. (1987) · Calcified Tissue International · doi:10.1007/bf02556671 · Cited by 357
Hughes, D. E., MacDonald, B. R., Russell, R. G., & Gowen, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114100 · Cited by 357 · cited 1×
“The formation of osteoclast-like cells in long-term cultures has been shown to be inhibited by five BPs with the same order of potency as found when these compounds are used therapeutically [ 15 ].”
BackgroundTwo modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Osteoclasts derived from haematopoietic stem cells
Ash, P., Loutit, J. F., & Townsend, K. M. S. (1980) · Nature · doi:10.1038/283669a0 · Cited by 319 · cited 2×
“This cell shares a common progenitor with the osteoclast [ 14 ].”
BackgroundCarano, A., Teitelbaum, S. L., Konsek, J. D., Schlesinger, P. H., & Blair, H. C. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114459 · Cited by 314 · cited 1×
“Dichloromethylene-bisphosphonate (ClzMBP) and APD inhibited the formation of resorption pits and also reduced numbers of osteoclasts [7-10].”
BackgroundEffects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy
Sato, M., & Grasser, W. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050107 · Cited by 264
Walker, D. G. (1975) · The Journal of experimental medicine · doi:10.1084/jem.142.3.651 · Cited by 236
Flanagan, A. M., & Chambers, T. J. (1989) · Bone and Mineral · doi:10.1016/0169-6009(89)90021-4 · Cited by 195 · cited 1×
“Dichloromethylen e-bisphosphonate (ClzMBP) and APD inhibited the formation of resorption pits and also reduced numbers of osteoclasts [ 7-10 ].”
BackgroundOrigin of osteoclasts from mononuclear leucocytes in regenerating newt limbs
Fischman, D. A., & Hay, E. D. (1962) · The Anatomical Record · doi:10.1002/ar.1091430402 · Cited by 195
Dr. Löwik, C. W. G. M., Van Der Pluijm, G., Van Der Wee-Pals, L. J. A., Van Treslong-De Groot, H. B., & Bijvoet, O. L. M. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030210 · Cited by 191 · cited 1×
“Evidence for two separate modes of inhibition of bone resorption came from the study of osteoclast development in embryonic mouse metacarpal rudiments [11, 12 ].”
Background
Cited by
Biochemical markers and skeletal metastases
Demers, L. M., Costa, L., & Lipton, A. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2919::aid-cncr7>3.0.co;2-z · Cited by 161
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l · Cited by 977
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Parfitt, A. M., Mundy, G. R., Roodman, G. D., Hughes, D. E., & Boyce, B. F. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110203 · Cited by 336
Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., & Nagata, N. (1996) · Bone · doi:10.1016/8756-3282(95)00426-2 · Cited by 161
Adachi, H., Igarashi, K., Mitani, H., & Shinoda, H. (1994) · Journal of Dental Research · doi:10.1177/00220345940730081301 · Cited by 163
Morony, S., Warmington, K., Adamu, S., Asuncion, F., Geng, Z., Grisanti, M., Tan, H. L., Capparelli, C., Starnes, C., Weimann, B., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1583 · Cited by 97
Li, J., Mori, S., Kaji, Y., Kawanishi, J., Akiyama, T., & Norimatsu, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.2042 · Cited by 95
Deckers, M. M. L., Van Beek, E. R., Van Der Pluijm, G., Wetterwald, A., Van Der Wee-Pals, L., Cecchini, M. G., Papapoulos, S. E., & Löwik, C. W. G. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.998 · Cited by 88
Inhibition of Tooth Eruption in the Rat by a Bisphosphonate
Grier, R. L., & Wise, G. E. (1998) · Journal of Dental Research · doi:10.1177/00220345980770011201 · Cited by 86
Inhibitory effect of a bisphosphonate (risedronate) on experimental periodontities in rats
Shoji, K., Horiuchi, H., & Shinoda, H. (1995) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1995.tb02134.x · Cited by 80
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor
Hiraga, T., Tanaka, S., Yamamoto, M., Nakajima, T., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00428-9 · Cited by 66
Biomimetic Collagen Nanofibrous Materials for Bone Tissue Engineering
Zheng, W., Zhang, W., & Jiang, X. (2010) · Advanced Engineering Materials · doi:10.1002/adem.200980087 · Cited by 69
Effects of Risedronate on Alveolar Bone Loss and Angiogenesis: A Stereologic Study in Rats
Cetinkaya, B. O., Keleș, G. Ç., Ayas, B., & Gürgör, P. N. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080041 · Cited by 59
Effects of two novel bisphosphonates on bone cells in vitro
Evans, C., & Braidman, I. P. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80055-4 · Cited by 48
The effect of growth hormone on craniofacial growth and dental maturation in Turner syndrome.
Hass, A. D., Simmons, K. E., Davenport, M. L., & Proffit, W. R. (2001) · PubMed · doi:10.1043/0003-3219(2001)071<0050:teogho>2.0.co;2 · Cited by 49
Acute effects of bisphosphonates on new and traditional markers of bone resorption
Pedrazzoni, M., Alfano, F. S., Gatti, C., Fantuzzi, M., Girasole, G., Campanini, C., Basini, G., & Passeri, M. (1995) · Calcified Tissue International · doi:10.1007/bf00298992 · Cited by 45
“Since bisphosphonates block the activity of osteoclasts, but may even increase their number [ 34 ], the use of this marker under these particular conditions may not be warranted.”
BackgroundDolbeare, F. A. (1995) · The Histochemical Journal · doi:10.1007/bf00175570 · Cited by 43
Ohishi, M., Chiusaroli, R., Ominsky, M. S., Asuncion, F., Thomas, C., Khatri, R., Kostenuik, P. J., & Schipani, E. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081026 · Cited by 37
Effect of Topical Administration of Monosodium Olpadronate on Experimental Periodontitis in Rats
Goya, J. A., Paez, H. A., & Mandalunis, P. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.77.1.1 · Cited by 39
Bone Resorption Inhibitor Alendronate Normalizes the Reduced Bone Thickness of TRPV5−/− Mice
Nijenhuis, T., van der Eerden, B. C. J., Hoenderop, J. G. J., Weinans, H., van Leeuwen, J. P. T. M., & Bindels, R. J. M. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080613 · Cited by 29
Dolbeare, F. A. (1995) · The Histochemical Journal · doi:10.1007/bf02389685 · Cited by 32
Holt, I., Davie, M. W. J., Braidman, I. P., & Marshall, M. J. E. (1994) · Calcified Tissue International · doi:10.1007/bf00297186 · Cited by 27
“First, we could not detect osteoclast progenitors in neonatal mouse parietal bones using bromodeoxyuridine labeling [ 29 ]; this is in distinction to osteoclast precursors (i.e., postmitotic) which were demonstrated on these bones.”
MethodSelf-citationDiastereoselective Synthesis of New Dialkylphosphorylhydrazones
Rodrigues, J. M., Sant’Anna, C. M. R., Rumjanek, V. M., & DaCosta, J. B. N. (2009) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426500903444366 · Cited by 24
Abe, Y., Kawakami, A., Nakashima, T., Ejima, E., Fujiyama, K., Kiriyama, T., Ide, A., Sera, N., Usa, T., Tominaga, T., et al. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.109757 · Cited by 23
Piper, K., BOYDE, A., & Jones, S. J. (1994) · Calcified Tissue International · doi:10.1007/bf00316291 · Cited by 24
“Con t rove r sy pers i s t s about the ways in which the bisphosphonates may inhibit resorption in vivo and in vitro [6], and whether or not its effects are confined to osteoclasts and their precursors [7].”
BackgroundEscudero, N. D., & Mandalunis, P. (2012) · Bone Marrow Research · doi:10.1155/2012/526236 · Cited by 16
“Our results are in keeping with those of other authors who used BrdU [11] and tritiated thymidine [25]; the latter are the only studies reported in the literature using nuclei staining to evaluate osteoclast recruitment.”
ResultNishikawa, M., Yamamoto, M., Murakami, T., Akatsu, T., Kugai, N., & Nagata, N. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.986 · Cited by 17
Marshall, M. J. E., Holt, I., & Davie, M. W. J. (1995) · Calcified Tissue International · doi:10.1007/bf00298618 · Cited by 14
“This supports our previous observation that OC progenitors are not present to any large extent on mouse parietal bones of this age [ 25 ].”
ResultSelf-citationThe bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects
Corrado, A., & Cantatore, F. P. (2011) · Reumatismo · doi:10.4081/reumatismo.2005.142 · Cited by 15
“In alcuni studi è stato verificato che il trattamento con BF stimola il reclutamento osteoclastico (6, 14), ma tale dato non è stato confermato; in numerosi modelli sperimentali, infatti, i BF inibiscono la formazione di osteoclasti da precursori midollari (15-19).”
BackgroundMorony, S., Warmington, K. S., Adamu, S., Asuncion, F., Geng, Z., Grisanti, M. S., Tan, H. L. E., Capparelli, C., Starnes, C. O., Dunstan, C. R., et al. (2005) · Cited by 13
Moran, E. L., Fornasier, V., & Bogoch, E. R. (2000) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100180605 · Cited by 9
Boche, M., & Pokharkar, V. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0558-9 · Cited by 8
Hiraga, T., Takada, M., Nakajima, T., & Ozawa, H. (1996) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(96)90492-9 · Cited by 7
Mechanisms of Action of Bisphosphonates as Inhibitors of Bone Resorption
Rogers, M. J., & Russell, R. G. G. (1996) · Medical intelligence unit · doi:10.1007/978-3-662-22505-9_7 · Cited by 5
Suzuki, M., Adachi, K., Sugimoto, T., Nakayama, H., & Doi, K. (1998) · Journal of Toxicologic Pathology · doi:10.1293/tox.11.65 · Cited by 3
Effect of a new bisphosphonate, YM175, on experimental periodontitis in hamsters.
Okamoto, M., Hasegawa, N., Maeda, N., Sugahara, N., & Fujita, H. (1994) · Japanese Journal of Oral Biology · doi:10.2330/joralbiosci1965.36.510
Metadata
- Authors
- Marshall, M. J., Holt, I., & John Davie, M. W.
- Affiliations
- Robert Jones and Agnes Hunt Orthopaedic Hospital (GB)
- Venue
- Calcified Tissue International
- Published
- 1993-01
- Volume
- 52
- Issue
- 1
- Pages
- 21-25
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W1979648009
- Cited by
- 37
- References
- 26
- Citations by year
- 2018: 1 · 2012: 1
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoclast recruitment, bisphosphonates, osteoclast precursors, bone resorption, bone marrow homing, osteoclast development, parietal bone
- MeSH terms
- Pamidronate, Animals, Bone Development, Bone Marrow, Bone Marrow Cells, Bromodeoxyuridine, Chromium, Diphosphonates, Erythrocytes, Leukocytes, Mice, Inbred CBA, Osteoclasts, Stem Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.